Bou­tique biotech agency guar­an­tees re­cruit­ment to drug spon­sors

Last year

Ful­ly Char­ac­ter­iz­ing a Man­u­fac­tur­ing Process is Crit­i­cal for Ad­vanc­ing Gene Ther­a­pies and Pri­or­i­tiz­ing Pa­tient Safe­ty

Last year

Com­pre­hen­sive char­ac­ter­i­za­tion of plas­mid and AAV gene ther­a­py prod­ucts with Forge Bi­o­log­ics’ hy­brid se­quenc­ing ap­proach

Last year

Biotech: A new path to cap­i­tal rais­ing in pub­lic and pri­vate mar­kets

Last year

Ge­net­ic Screen­ing Projects Make Japan A Ris­ing Op­tion For Clin­i­cal Tri­als

Last year

Break­ing bar­ri­ers to in­no­va­tion: In­te­grat­ing Re­search and Busi­ness De­vel­op­ment to ac­cel­er­ate nov­el ther­a­pies

Last year

Sol­id Tu­mors: The Next Fron­tier of Can­cer Im­muno-ther­a­py

Last year

The next phase of de­cen­tral­iza­tion in clin­i­cal tri­als

Last year

Ear­ly pre­dic­tion of out­comes in DL­B­CL clin­i­cal tri­als through MRD test­ing

Last year

Un­rav­el­ing the Com­plex­i­ties of Can­cer through More Hu­man-rel­e­vant Mod­els

Last year

Clin­i­cal Stud­ies In Japan To­day: An­oth­er Look At The World’s Sec­ond-Largest Pre­scrip­tion Drug Mar­ket In A Post-Pan­dem­ic World

Last year

Con­nec­tiv­i­ty in mo­tion: The art and sci­ence of cre­at­ing ex­pe­ri­ences that in­form and in­spire health­care pro­fes­sion­als

Last year

The Rare Kid­ney Dis­ease Play­book: How New Re­search and In­no­va­tion is Trans­form­ing the RKD Treat­ment Land­scape

Last year

Can Biotech In­no­va­tion With­stand Dis­rup­tion?

Last year

Re­think­ing Treat­ments for GAD: Progress in Sight for Pa­tients in Need

Last year

Ex­plor­ing new fron­tiers in rare dis­ease re­search to meet the needs of pa­tients

Last year

A Wind­ing Road Ahead for Biotech?

Last year

I'll be in Lon­don next week with the End­points crew and a great line­up of biotech ex­perts and in­sid­ers. Join us

Last year

CMIC: Japan’s first and largest CRO con­tin­ues 30-year evo­lu­tion to help glob­al spon­sors nav­i­gate the com­plex lo­cal mar­ket

Last year

5 Pa­tient En­gage­ment & Re­cruit­ment Trends, and How to Keep Up with Them

Last year

Da­ta Qual­i­ty 2.0: The Fu­ture of Re­al-World Ev­i­dence

Last year

Ad­vanc­ing Sleep Med­i­cine: Pi­o­neer­ing Re­search and Car­dio­vas­cu­lar Health in Nar­colep­sy

Last year

In­no­va­tion and growth: key in­gre­di­ents for health­care M&A

Last year

How Clover­tex blends be­spoke and off-the-rack cloud com­put­ing in Phar­ma

Last year
First page Previous page 123456 Next page Last page
A service from the Financial Times